We are live on ! Find out more
FCM

Farallon Capital Management Portfolio holdings

AUM $17.5B
1-Year Est. Return 50.95%
This Fund
S&P 500
This Quarter Est. Return
+8.01%
1 Year Est. Return
+50.95%
3 Year Est. Return
+148.38%
5 Year Est. Return
+206.05%
10 Year Est. Return
+1,475.31%
AUM
$20.1B
AUM Growth
+$3.5B
Cap. Flow
+$2.5B
Cap. Flow %
12.41%
Top 10 Hldgs %
33.13%
Holding
257
New
120
Increased
40
Reduced
39
Closed
20

Top Buys

Rank Stock Value
1
ALXN
Alexion Pharmaceuticals
ALXN
+$546M
2
WTW icon
Willis Towers Watson
WTW
+$471M
3
MA icon
Mastercard
MA
+$344M
4
GWPH
GW Pharmaceuticals Plc American Depositary Shares
GWPH
+$240M
5
BBL
BHP Group Plc American Depositary Shares (Each representing two Ordinary Shares)
BBL
+$238M

Top Sells

Rank Stock Value
1
TIF
Tiffany & Co.
TIF
+$301M
2
NYT icon
New York Times
NYT
+$209M
3
V icon
Visa
V
+$194M
4
ELV icon
Elevance Health
ELV
+$145M
5
ABBV icon
AbbVie
ABBV
+$123M

Sector Composition

Rank Sector Weight
1 Healthcare 34.84%
2 Financials 13.62%
3 Communication Services 11.15%
4 Technology 9.41%
5 Industrials 7.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FDMT icon
226
4D Molecular Therapeutics
FDMT
$562M
– –
-100,000
Closed -$4.14M
IVA
227
Inventiva
IVA
$1.13B
– –
-160,000
Closed -$2.32M
MASS icon
228
908 Devices
MASS
$364M
– –
-75,000
Closed -$4.27M
MRVL icon
229
CALL
Marvell Technology
MRVL
$196B
– –
-125,000
Closed -$5.94M
NTLA icon
230
Intellia Therapeutics
NTLA
$1.67B
– –
-225,000
Closed -$12.2M
PACB icon
231
Pacific Biosciences
PACB
$370M
– –
-2,100,000
Closed -$54.5M
PRAX icon
232
Praxis Precision Medicines
PRAX
$10.1B
– –
-16,667
Closed -$13.8M
SPRY icon
233
ARS Pharmaceuticals
SPRY
$612M
– –
-47,620
Closed -$2.21M
STTK icon
234
Shattuck Labs
STTK
$694M
– –
-100,000
Closed -$5.24M
XPO icon
235
XPO
XPO
$23.7B
– –
-318,053
Closed -$13.1M
ALPN
236
DELISTED
Alpine Immune Sciences Inc
ALPN
– –
-200,000
Closed -$2.52M
ISEE
237
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
– –
-754,740
Closed -$5.21M
HMCOU
238
DELISTED
HumanCo Acquisition Corp. Unit
HMCOU
– –
-400,000
Closed -$4.41M
TINV.U
239
DELISTED
Tiga Acquisition Corp. Units, each consisting of one Class A ordinary share and one half of one warrant
TINV.U
– –
-1,080,000
Closed -$11.4M
CAS.U
240
DELISTED
Cascade Acquisition Corp. Units, each consisting of one share of Class A Common Stock and one-half o
CAS.U
– –
-990,000
Closed -$10.3M
ACIA
241
DELISTED
Acacia Communications Inc
ACIA
– –
-100,000
Closed -$7.3M
TIF
242
DELISTED
Tiffany & Co.
TIF
– –
-2,287,000
Closed -$301M
BMY.RT
243
DELISTED
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
– –
-21,400,000
Closed -$14.8M
6 7 8 9
10

Similar funds

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
MCM
MAI Capital Management Independence, Ohio $17.7B AUM 18.87% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
CM
Caption Management Oklahoma City, Oklahoma $17.1B AUM 70.99% 1-Year Est. Return
ASRS
Arizona State Retirement System Phoenix, Arizona $17.1B AUM 30.52% 1-Year Est. Return
PP
Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return
VMPIC
Varma Mutual Pension Insurance Co Helsinki, Finland $17B AUM 24.09% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Farallon Capital Management's Q1 2021 Portfolio in Review

As of Q1 2021, Farallon Capital Management held 257 positions worth $20.1B, up 21% from $16.6B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Farallon Capital Management deployed $2.5B of net new capital in Q1 2021, opening 120 new positions and adding to 40 existing holdings. Its largest new stake was Mastercard: 985,920 shares worth $351M.

By sector, the portfolio is most concentrated in Healthcare at 35% of assets, down from 38% a quarter earlier, followed by Financials and Communication Services.

On the sell side, the largest reduction was New York Times, an estimated $209M trimmed.

  • Farallon Capital Management's largest Q1 2021 buy was Mastercard: 985,920 shares worth $351M.
  • Farallon Capital Management added most to Alexion Pharmaceuticals in Q1 2021, an estimated $546M increase.
  • Farallon Capital Management's biggest Q1 2021 reduction was New York Times, cutting an estimated $209M.
  • Farallon Capital Management fully exited Tiffany & Co. in Q1 2021, selling an estimated $301M.
  • Farallon Capital Management's ten largest holdings make up 33% of its $20.1B portfolio in Q1 2021.
  • Farallon Capital Management opened 120 new positions and closed 20 in Q1 2021.
  • Farallon Capital Management's portfolio value rose 21% quarter-over-quarter to $20.1B.

Based on Farallon Capital Management's 13F filing for Q1 2021, filed 17 May 2021.